Covered recipient · General Payments record
PETER B SPENCER
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$1,438.76
- Reported across 85 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $266.26 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $169.13 | 12 |
| SK Life Science, Inc. | $26.39 | 1 |
| Teva Pharmaceuticals USA, Inc. | $20.17 | 1 |
| Aucta Pharmaceuticals, Inc. | $19.20 | 1 |
| Genentech USA, Inc. | $17.44 | 1 |
| Lilly USA, LLC | $13.93 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $30.81 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146372 | CMS |
| ABBVIE INC. | $7.14 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146374 | CMS |
| ABBVIE INC. | $19.42 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146376 | CMS |
| ABBVIE INC. | $8.38 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146378 | CMS |
| ABBVIE INC. | $7.91 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146380 | CMS |
| ABBVIE INC. | $9.53 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146382 | CMS |
| ABBVIE INC. | $27.15 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146384 | CMS |
| ABBVIE INC. | $20.98 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146386 | CMS |
| ABBVIE INC. | $8.44 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146388 | CMS |
| ABBVIE INC. | $5.23 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146390 | CMS |
| ABBVIE INC. | $22.07 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146392 | CMS |
| ABBVIE INC. | $2.07 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146394 | CMS |
| Aucta Pharmaceuticals, Inc. | $19.20 | 11/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147907480 | CMS |
| Genentech USA, Inc. | $17.44 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133088419 | CMS |
| Lilly USA, LLC | $13.93 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135290520 | CMS |
| SK Life Science, Inc. | $26.39 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154124279 | CMS |
| Teva Pharmaceuticals USA, Inc. | $20.17 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151597776 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.